MYGN
Myriad Genetics Inc
Price:  
22.72 
USD
Volume:  
326,897.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MYGN Relative Valuation

-417.1%
Upside

As of 2024-02-26, the Relative Valuation of Myriad Genetics Inc (MYGN) is (72.06) USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.72 USD, the upside of Myriad Genetics Inc based on Relative Valuation is -417.1%.

The range of the Relative Valuation is (70.66) - (72.58) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 22.8x - 28.6x 25.1x
Forward P/E multiples 19.4x - 23.4x 21.4x
Fair Price (70.66) - (72.58) (72.06)
Upside -411.0% - -419.5% -417.1%
22.72 USD
Stock Price
(72.06) USD
Fair Price

MYGN Relative Valuation - Historical P/E Data

Date P/E
2024-02-23 -7.33
2024-02-22 -7.45
2024-02-21 -7.39
2024-02-20 -7.58
2024-02-16 -7.50
2024-02-15 -7.61
2024-02-14 -7.55
2024-02-13 -6.88
2024-02-12 -7.44
2024-02-09 -7.10
2024-02-08 -7.14
2024-02-07 -7.09
2024-02-06 -7.25
2024-02-05 -7.05
2024-02-02 -6.86
2024-02-01 -6.97
2024-01-31 -6.90
2024-01-30 -7.26
2024-01-29 -7.33
2024-01-26 -7.17
2024-01-25 -7.13
2024-01-24 -6.96
2024-01-23 -6.91
2024-01-22 -6.89
2024-01-19 -6.55
2024-01-18 -6.52
2024-01-17 -6.46
2024-01-16 -6.64
2024-01-12 -6.41
2024-01-11 -6.37
2024-01-10 -5.89
2024-01-09 -5.83
2024-01-08 -5.85
2024-01-05 -5.68
2024-01-04 -5.78
2024-01-03 -5.86
2024-01-02 -6.13
2023-12-29 -6.18
2023-12-28 -6.36
2023-12-27 -6.38
2023-12-26 -6.57
2023-12-22 -6.55
2023-12-21 -6.60
2023-12-20 -6.56
2023-12-19 -6.88
2023-12-18 -6.60
2023-12-15 -6.69
2023-12-14 -6.86
2023-12-13 -6.74
2023-12-12 -6.15